Best Cheap Stocks to Buy Today: 04/23/26

Let’s look at three of the best cheap stocks to buy today.

Price is important to us all, especially during tough economic times. That is true in all aspects of life, including investing.

Finding that gem stock – buying at a cheap price and enjoying the upside as it fulfills its potential and grows – is fundamental in the appeal of investing.

We’ve highlighted three stocks via our Stock Screener, which could be worth following. You can click on their ticker to find more comprehensive TipRanks data on their business model, earnings history and latest news.

Immunic (IMUX)

Immunic is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in a Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease.

According to the TipRanks TopStocks analysis, the stock’s price is currently $0.87 per share with a market cap of around $117.5 million. Based on 6 Wall Street analysts offering 12-month price targets for Immunic in the last 3 months, the average price target is $4.38 with a high forecast of $7.00 and a low forecast of $2.50. The average price target represents a 401.78% upside.

Myles Minter analyst at William Blair recently gave the stock a Buy rating. This is due to a combination of factors, he said, centered on Immunic’s lead asset, vidofludimus calcium, and its positioning versus emerging BTK inhibitors in relapsing multiple sclerosis.

Seanergy Maritime (SHIP)

Seanergy Maritime Holdings Corp is a shipping company, which engages in the seaborne transportation of dry bulk commodities worldwide. It operates a fleet of 17 Capesize vessels with a cargo-carrying capacity of approximately 3,011,083 deadweight tons.

Its current stock price is $14.31 with a market cap of just over $300 million. Based on 3 Wall Street analysts offering 12-month price targets for Seanergy Maritime in the last 3 months. The average price target is $18.00 with a high forecast of $20.00 and a low forecast of $17.00. The average price target represents a 25.79% upside.

BioRestorative Therapies (BRTX)

It is a life sciences company, focused on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company’s two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.

It has a share price of $0.22 and a market cap of $5.73 million. Based on 2 Wall Street analysts offering 12-month price targets for BioRestorative Therapies in the last 3 months. The average price target is $8.00, implying an upside of 3615.75%, with a high forecast of $15.00 and a low forecast of $1.00.

It recently announced a strategic collaboration with 203 Creates designed to advance BioRestorative’s biocosmeceutical platform. It also announced blinded data from its Phase 2 clinical trial evaluating hypoxic-cultured mesenchymal stem cells for the treatment of chronic lumbar disc disease, with 50% or more of treated patients reporting improvements greater than 50% across key pain measures.